SCHEMBL8370302

SCHEMBL8370302

[N-]=[N+]=C1C=CC(=C2C=CC(=[N+]=[N-])C=C2)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28925615 0.72
SCHEMBL28799355 0.65
SCHEMBL6934750 0.59
SCHEMBL28638627 0.50 APP (0.31)
SCHEMBL2751602 0.50 ALDH1A1 (0.73)
SCHEMBL4552479 0.50
Benzene SCHEMBL8162907 0.42
SCHEMBL674049 0.42
SCHEMBL9005288 0.42
SCHEMBL29374945 0.39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999066878-A2 USE OF BIS(DIAZO) COMPOUND AS ANTIFUNGAL AGENTS ALPHA-BETA TECHNOLOGY, INC. (US) 1999-12-29 WO claimed
WO-1999066878-A2 USE OF BIS(DIAZO) COMPOUND AS ANTIFUNGAL AGENTS ALPHA-BETA TECHNOLOGY, INC. (US) 1999-12-29 WO disclosed
WO-1999066878-A2 USE OF BIS(DIAZO) COMPOUND AS ANTIFUNGAL AGENTS ALPHA-BETA TECHNOLOGY, INC. (US) 1999-12-29 WO disclosed
EP-0287909-B1 AMYLOIDOSIS AND ALZHEIMER'S DISEASE DIAGNOSTIC ASSAY AND REAGENTS THEREFOR SALUTAR, INC. (US) 1992-09-02 EP disclosed
US-5039511-A Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor SALUTAR, INC. (US) 1991-08-13 US disclosed
US-5008099-A Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor SALUTAR, INC. (US) 1991-04-16 US disclosed
US-4933156-A Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor SALUTAR, INC. (US) 1990-06-12 US disclosed